Author Archives: ScienceDirect Publication: Journal of Infection

Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination

Posted on by

Publication date: September 2023

Source: Journal of Infection, Volume 87, Issue 3

Author(s): Ilenia Varasi, Alessia Lai, Lia Fiaschi, Annalisa Bergna, Antonella Gatti, Barbara Caimi, Camilla Biba, Carla Della Ventura, Claudia Balotta, Agostino Riva, Gianguglielmo Zehender, Maurizio Zazzi, Ilaria Vicenti

Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan

Posted on by

Publication date: September 2023

Source: Journal of Infection, Volume 87, Issue 3

Author(s): Hung-Chieh Su, Zi-Lun Lai, Yu-Chang Chang, Meng-Yu Cheng, Wen-Hsin Hsih, Yi-Jhen Chen, Chia-Huei Chou, Chieh-Lung Chen, Yu-Chao Lin, Tsai-Hsiu Lin, Chiung-Tzu Hsiao, Mao-Wang Ho, Hong-Mo Shih, Po-Ren Hsueh, Der-Yang Cho

Asymptomatic <em>Plasmodium falciparum</em> infection evades triggering a host transcriptomic response

Posted on by

Publication date: September 2023

Source: Journal of Infection, Volume 87, Issue 3

Author(s): Diana Ahu Prah, Claire Dunican, Linda Eva Amoah, Mahdi Moradi Marjaneh, Myrsini Kaforou, Asa Nordgren, William Jones-Warner, Yaw Aniweh, Gordon A. Awandare, Aubrey J. Cunnington, Julius Clemence Hafalla

Electronic nose in differentiating and ascertaining clinical status among patients with pulmonary nontuberculous mycobacteria: A prospective multicenter study

Posted on by

Publication date: September 2023

Source: Journal of Infection, Volume 87, Issue 3

Author(s): Meng-Rui Lee, Hung-Ling Huang, Wei-Chang Huang, Shang-Yu Wu, Pang-Chun Liu, Jui-Ching Wu, Meng-Hsuan Cheng, Chau-Chyun Sheu, Kea-Tiong Tang, Jann-Yuan Wang, Chao-Chi Ho, Jin-Yuan Shih, Inn-Wen Chong

Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial

Posted on by

Publication date: September 2023

Source: Journal of Infection, Volume 87, Issue 3

Author(s): Christian Taucher, Rajeka Lazarus, Hanna Dellago, Gabriele Maurer, Petronela Weisova, Irena Corbic-Ramljak, Katrin Dubischar, Anders Lilja, Susanne Eder-Lingelbach, Romana Hochreiter, Juan Carlos Jaramillo, Helga Junker, Michael Krammer, Petra Pusic, Benedicte Querton, Julian Larcher-Senn, Markus Hoffmann, Stefan Pöhlmann, Adam Finn, the Valneva Phase 3 Booster Trial Group

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial

Posted on by

Publication date: September 2023

Source: Journal of Infection, Volume 87, Issue 3

Author(s): Eimear Kelly, Melanie Greenland, Philip C.S. de Whalley, Parvinder K. Aley, Emma L. Plested, Nisha Singh, Stanislava Koleva, Sharon Tonner, Grace C. Macaulay, Robert C. Read, Mary Ramsay, J.Claire Cameron, David P.J. Turner, Paul T. Heath, Jolanta Bernatoniene, Philip Connor, Katrina Cathie, Saul N. Faust, Indraneel Banerjee, Liberty Cantrell